Assignment history

Inventors

• Frank Borges Llosa: Employer at time of filing not explicitly stated, but rights assigned to Ketoneaid Inc.
• Stephen Zarpas: Employer at time of filing not explicitly stated, but rights assigned to Ketoneaid Inc.

Both inventors assigned their interest in the patent to Ketoneaid Inc., the original assignee, which is standard practice. There are no unusual patterns, such as inventors departing the original assignee shortly after filing, apparent from the provided data.

Original assignee

The entity named on the issued patent is Ketoneaid Inc.

Ketoneaid Inc. manufactures and sells exogenous ketone supplements, including beverages and esters, directly embodying the claims of US 12,037,567. Their primary line of business is the development and commercialization of ketone-based nutritional products for health, performance, and ketogenic diet support. As of today's date, Ketoneaid Inc. appears to be an active, operating company.

Assignment timeline

• 2016-04-21 (executed) / recorded 2023-11-09 — Reel 065511/0785
  • Conveyance: Assignment of Assignors Interest
  • Assignor: ZARPAS, STEVEN M.
  • Assignee: KETONEAID, INC.
  • Correspondent: Not available from provided data.
  • Context: Inventor assignment to company, likely covering future inventions in this patent family.
• 2023-07-09 (executed) / recorded 2023-11-09 — Reel 065511/0815
  • Conveyance: Assignment of Assignors Interest
  • Assignor: LLosa, Frank Borges
  • Assignee: KETONEAID, INC.
  • Correspondent: Not available from provided data.
  • Context: Inventor assignment to company, preceding the filing of this application.

Timeline diagram

timeline
    title Ownership of US 12037567
    2016 : Inventor Zarpas assigns to Ketoneaid
    2023 : Inventor Llosa assigns to Ketoneaid
         : Application filed by Ketoneaid
    2024 : Patent issued to Ketoneaid Inc

NPE / troll-pattern signals

1. Shell-entity transfer — Not present. The patent remains with Ketoneaid Inc., an operating company that sells products related to the claimed invention.
2. Known asserter in the chain — Not present. Ketoneaid Inc. is not listed as a known NPE.
3. Repeat correspondent across the chain — Unclear. Correspondent information for the recorded assignments is not available in the provided data.
4. Cascading transfers — Not present. There are no multiple consecutive transfers of the patent from Ketoneaid Inc. to other entities. The recorded assignments are from the inventors to the initial assignee.
5. Pre-litigation transfer — Not present. There is no identified litigation involving this patent.
6. Bankruptcy fire-sale — Not present. There is no information indicating Ketoneaid Inc. has filed for bankruptcy.
7. Privateering — Not present. No evidence suggests Ketoneaid Inc. has transferred the patent to an NPE for assertion against competitors on its behalf.
8. Defensive aggregator (anti-NPE) — Not present. The patent is held by an operating company, not a defensive aggregator.

Verdict

Insufficient data to definitively rule out future NPE activity, but the current pattern points toward Operating-company ownership.

The patent is currently assigned to Ketoneaid Inc., an operating company that manufactures and sells products embodying the patented technology. The only recorded assignments are standard transfers of inventor rights to the company (Reel 065511/0785 and 065511/0815). There are no recorded transfers from Ketoneaid Inc. to any other entity, nor any signals typically associated with NPE activity. Without correspondent information or a history of litigation, a definitive ruling on assertion strategy is not possible, but current ownership aligns with an operating company.
USPTO Assignment Center Search: https://assignmentcenter.uspto.gov/patents/12037567